The Role and Mechanisms of G protein-coupled receptors in Parkinson's disease
- 11 June 2025
- journal article
- review article
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (9) , 4121-4135
Abstract
This comprehensive review meticulously examines the pivotal and multifaceted role of G protein-coupled receptors (GPCRs) in the complex pathogenesis of Parkinson's disease (PD), a neurodegenerative disorder that profoundly impacts motor control and cognitive function. Initially, we introduce the fundamental concepts of GPCRs, delving into their intricate structures and diverse functions within the nervous system, highlighting their importance as key players in cellular communication and signal transduction. Following this foundational overview, we thoroughly analyze specific GPCRs that have been closely associated with the onset and progression of PD, exploring the intricate mechanisms by which they influence disease progression through the nuanced regulation of neurotransmitter release, complex signaling pathways, and crucial aspects of cell survival. Furthermore, we engage in a detailed discussion regarding the promising prospects of GPCRs as potential therapeutic targets for intervention in PD, emphasizing the significance of recent groundbreaking research findings that shed light on the therapeutic implications of modulating GPCR activity. Finally, drawing upon the latest advancements in research, we propose insightful directions for future studies, as well as a thoughtful consideration of the myriad challenges that lie ahead in this dynamic and rapidly evolving field of study, which holds the potential to enhance our understanding of PD and pave the way for innovative treatment strategies. Graphical AbstractKeywords
This publication has 163 references indexed in Scilit:
- Spinal Cord Subacute Combined Degeneration Mimicked by Copper Deficiency: A Case ReportClinical Case Reports, 2025
- Activation of G protein‐coupled receptor 39 alleviates neuropathic pain and chronic inflammationJournal of Biochemical and Molecular Toxicology, 2023
- Microglia and astrocyte activation is region‐dependent in the α‐synuclein mouse model of Parkinson's diseaseGlia, 2022
- Heritability Enrichment Implicates Microglia in Parkinson's Disease PathogenesisAnnals of Neurology, 2021
- Activation of alpha‐2 adrenergic receptors stimulates GABA release by astrocytesGlia, 2019
- Upstream regulators of phosphoinositide 3‐kinase and their role in diseasesJournal of Cellular Physiology, 2019
- Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomasGlia, 2010
- Allosteric ligands for G protein-coupled receptors: A novel strategy with attractive therapeutic opportunitiesMedicinal Research Reviews, 2009
- Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicityGlia, 2008
- G protein‐coupled receptor 84, a microglia‐associated protein expressed in neuroinflammatory conditionsGlia, 2007